| |
| |
|
| Insider
Information: |
Otto Dawn Parsell |
| Relationship: |
EVP, Clinical Developm... |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
3,465 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
3,465 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Tricida, Inc. |
TCDA |
EVP, Clinical Developm... |
2021-12-31 |
3,465 |
2019-01-07 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TCDA |
Tricida, Inc. |
EVP, Clinical Development |
• – – |
2021-12-31 |
4 |
D |
$9.56 |
$15,047 |
D/D |
(1,574) |
3,465 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
EVP, Clinical Development |
• – – |
2020-09-10 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
4,637 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
EVP, Clinical Development |
• – – |
2020-05-08 |
4 |
AS |
$31.98 |
$95,940 |
D/D |
(3,000) |
255 |
0 |
% |
|
| TCDA |
Tricida, Inc. |
EVP, Clinical Development |
• – – |
2020-05-08 |
4 |
OE |
$1.68 |
$9,099 |
D/D |
3,000 |
1,692 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
EVP, Clinical Development |
• – – |
2020-05-05 |
4 |
AS |
$30.05 |
$37,680 |
D/D |
(1,250) |
255 |
0 |
% |
|
| TCDA |
Tricida, Inc. |
EVP, Clinical Development |
• – – |
2020-05-05 |
4 |
OE |
$1.68 |
$2,421 |
D/D |
1,250 |
707 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
EVP, Clinical Development |
• – – |
2020-04-29 |
4 |
AS |
$31.98 |
$95,940 |
D/D |
(3,000) |
255 |
0 |
% |
|
| TCDA |
Tricida, Inc. |
EVP, Clinical Development |
• – – |
2020-04-29 |
4 |
OE |
$1.68 |
$8,450 |
D/D |
3,000 |
778 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
EVP, Clinical Development |
• – – |
2020-04-28 |
4 |
OE |
$1.68 |
$2,100 |
D/D |
1,250 |
1,505 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
EVP, Clinical Development |
• – – |
2020-04-28 |
4 |
AS |
$29.98 |
$37,475 |
D/D |
(1,250) |
255 |
0 |
% |
|
| TCDA |
Tricida, Inc. |
EVP, Clinical Development |
• – – |
2020-03-02 |
4 |
AS |
$31.78 |
$135,316 |
D/D |
(4,250) |
255 |
0 |
% |
|
| TCDA |
Tricida, Inc. |
EVP, Clinical Development |
• – – |
2020-03-02 |
4 |
OE |
$1.68 |
$10,550 |
D/D |
4,250 |
778 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Sr VP, Clinical Development |
• – – |
2020-02-03 |
4 |
AS |
$35.58 |
$156,668 |
D/D |
(4,250) |
255 |
0 |
% |
|
| TCDA |
Tricida, Inc. |
Sr VP, Clinical Development |
• – – |
2020-02-03 |
4 |
OE |
$1.68 |
$10,550 |
D/D |
4,250 |
778 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Sr VP, Clinical Development |
• – – |
2020-01-02 |
4/A |
OE |
$1.68 |
$7,140 |
D/D |
4,250 |
4,505 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Sr VP, Clinical Development |
• – – |
2020-01-02 |
4 |
AS |
$36.84 |
$157,421 |
D/D |
(4,250) |
255 |
0 |
% |
|
| TCDA |
Tricida, Inc. |
Sr VP, Clinical Development |
• – – |
2020-01-02 |
4 |
OE |
$1.68 |
$7,140 |
D/D |
4,250 |
2,620 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Sr VP, Clinical Development |
• – – |
2019-10-28 |
4 |
AS |
$37.11 |
$197,438 |
D/D |
(5,300) |
0 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Sr VP, Clinical Development |
• – – |
2019-10-28 |
4 |
OE |
$1.68 |
$12,294 |
D/D |
5,300 |
4,774 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Sr VP, Clinical Development |
• – – |
2019-09-25 |
4 |
AS |
$32.40 |
$172,257 |
D/D |
(5,300) |
0 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Sr VP, Clinical Development |
• – – |
2019-09-25 |
4 |
OE |
$1.68 |
$8,904 |
D/D |
5,300 |
5,300 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Sr VP, Clinical Development |
• – – |
2019-08-28 |
4 |
AS |
$33.67 |
$168,455 |
D/D |
(5,000) |
0 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Sr VP, Clinical Development |
• – – |
2019-08-28 |
4 |
OE |
$1.68 |
$8,400 |
D/D |
5,000 |
3,500 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Sr VP, Clinical Development |
• – – |
2019-07-29 |
4 |
OE |
$1.68 |
$8,400 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Sr VP, Clinical Development |
• – – |
2019-07-29 |
4 |
AS |
$31.19 |
$155,950 |
D/D |
(5,000) |
0 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
